Skip to content
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Aureus Santa Marta
Education
MyMedi.ca
Contact
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Aureus Santa Marta
Education
MyMedi.ca
Contact
Instagram
Twitter
Linkedin
Linkedin
Twitter
Instagram
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Aureus Santa Marta
Education
MyMedi.ca
Contact
×
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Aureus Santa Marta
Education
MyMedi.ca
Contact
Avicanna Files Complete Patent Specifications Relating to a Novel Cannabinoid Formulation for Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy
20 October 2022
Avicanna Introduces a New Medical Cannabis Education Online Portal, “Avicenna Academy” for Health Care Professionals
18 October 2022
Avicanna Expands its Epilepsy Research Program with a New Collaboration with the University of Toronto
15 September 2022
Avicanna Reports Q2 2022 Financial Statement
16 August 2022
Avicanna and Ei. Ventures Enter into an Agreement to Develop and Commercialize Adaptogen Nutraceuticals
20 July 2022
RE+PLAY ANNOUNCES THE NBPA AS AN OFFICIAL PARTNER
12 July 2022
« Prev
1
2
3
4
5
6
7
Next »